Lymphocyte Telomere Length Is Long in <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers Regardless of Cancer-Affected Status
Karen A. Pooley(University of Cambridge), Alison M. Dunning(University of Cambridge), Zosia Miedzybrodzka(NHS Grampian), Julian Adlard(Chapel Allerton Hospital), Antonis C. Antoniou(Weatherford College), Louise Izatt(Guy's and St Thomas' NHS Foundation Trust), Daniel Barrowdale(University of Cambridge), Douglas F. Easton(University of Cambridge), Lucy Side(Unknown), Marc Tischkowitz(University of Cambridge), Patrick J. Morrison(Belfast Health and Social Care Trust), Catherine Houghton(Ollscoil na Gaillimhe – University of Galway), Jacqueline Eason(Nottingham University Hospitals NHS Trust), Michael J. Kennedy(University of Virginia), Alex Murray(University Medical Center Utrecht), Huw Dorkins(London North West Healthcare NHS Trust), D. Gareth Evans(Manchester Academic Health Science Centre), Emma McCann(University of Liverpool), Julian Bardwell(Babraham Institute), Trevor Cole(Birmingham Women's Hospital), Mark T. Rogers, Alan Donaldson(University Hospitals Bristol NHS Foundation Trust), Lisa Walker(Oxford University Hospitals NHS Trust), Mary Porteous(University of Edinburgh), Fiona Douglas(University of Southern California), Lesley McGuffog(University of Cambridge), Radka Platte(University of Cambridge), Rosemarie Davidson(The Netherlands Cancer Institute), Steve D. Ellis(University of Cambridge), Carole Brewer(Royal Devon and Exeter Hospital), Elena Fineberg, Shirley Hodgson(St Thomas' Hospital), Jackie Cook(Sheffield Children's Hospital), Debra Frost(University of Cambridge), Rosalind A. Eeles(Royal Marsden NHS Foundation Trust)
Cited by 23
Related Papers
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
The evolutionary history of lethal metastatic prostate cancer
|Nature|2015|1.4k